Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:AGE

AgeX Therapeutics (AGE) Stock Price, News & Analysis

AgeX Therapeutics logo

About AgeX Therapeutics Stock (NYSE:AGE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.22
$16.51
52-Week Range
N/A
Volume
3,700 shs
Average Volume
3,849 shs
Market Capitalization
$11.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AgeX Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AGE Stock News Headlines

Serina Therapeutics initiated with a Buy at JonesResearch
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Serina Therapeutics sells UniverXome subsidiary
Serina Therapeutics Inc (SER)
Serina Therapeutics to Present at the 14th Annual Injectables Summit
Russell Skibsted's Net Worth
See More Headlines

AGE Stock Analysis - Frequently Asked Questions

AgeX Therapeutics shares split on Monday, March 18th 2024.The 8-5 split was announced on Monday, March 18th 2024. The newly issued shares were distributed to shareholders after the market closes on Monday, March 18th 2024. An investor that had 100 shares of stock prior to the split would have 160 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that AgeX Therapeutics investors own include Allena Pharmaceuticals (ALNA), Biocept (BIOC), Palatin Technologies (PTN), Aadi Bioscience (AADI), Arbutus Biopharma (ABUS) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:AGE
CIK
1708599
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($13.0282)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.80 million
Net Margins
-10,424.65%
Pretax Margin
-10,430.28%
Return on Equity
N/A
Return on Assets
-120.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$140 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($16.07) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,080,000
Free Float
1,008,000
Market Cap
$11.99 million
Optionable
Not Optionable
Beta
1.18
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:AGE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners